William A Houlihan

Director Houlihan purchases 20,000 shares at $1.14–$1.19; stock down 18.9% in 30 days, 23.1% in 90 days.

William A Houlihan, a director at Lument Finance Trust, Inc., made 2 separate purchases totaling 20,000 shares for $23,300.00 (blended average $1.16) on 2026-05-20 and 2026-05-21, raising his post-transaction holdings to 280.7K shares. The timing is concerning: the current price of $1.03 is -61.0% from the 52-week high of $2.64, and the stock has declined 18.9% over the past 30 days and 23.1% over the past 90 days since these purchases. Houlihan's prior 3 measurable trades at LFT all showed negative 90-day returns (ranging from -17.6% to -18.5%), with a 0% win rate at this ticker, suggesting a consistent pattern of purchases made before further declines. The company's fundamentals remain strained, having reported a negative full-year net income, which adds downside risk context to this accumulation.

Director Houlihan buys 5,000 shares of LFT at $1.30; stock down -54.9% from 52-week high, down -10.8% in 30 days.

HOULIHAN WILLIAM A (Director) purchased 5,000 shares at $1.30 on 2026-03-27, bringing his holdings to 260,732 shares. The purchase occurs against a backdrop of significant recent price weakness: the stock is currently trading at $1.24, down -10.8% over the past 30 days and down -12.1% over 90 days, while sitting -54.9% from its 52-week high of $2.75. Houlihan's prior buy at this same ticker on 2025-11-25 (similarly a discretionary open-market purchase) experienced a -8.2% 30-day return and -17.6% 90-day return, representing a pattern of unfavorable timing outcomes. The underlying company is unprofitable on a full-year basis, and his 0.00% win rate across his cross-ticker track record of 4 prior buys (averaging -8.2% at 30 days, -17.6% at 90 days) suggests a consistent pattern of purchases followed by further declines.

Director William Houlihan buys 15,000 LFT shares at $1.29; stock down 57.2% from 52-week high of $2.83

Director William A. Houlihan purchased 15,000 shares at $1.29 on 2026-03-26, increasing his holdings to 255,732 shares. The timing is notable: the stock currently trades at $1.21, down 57.2% from its 52-week high of $2.83, and has declined 9.7% over the last 30 days and 17.1% over 90 days. Houlihan's prior buy on 2025-11-25 at this ticker resulted in a 90-day loss of 17.6%, and his cross-ticker track record shows zero wins across four prior buys with an average 90-day return of -17.6%. The company reported negative full-year net income despite a positive quarterly result of $1.8M, and carries a market cap of $63.4M. This purchase occurs during a period of sustained price weakness and follows a pattern of Houlihan's prior buys not reversing into gains at the 90-day horizon.

Director William A. Houlihan bought 3,000 shares of Lument Finance Trust at $1.59 amid -43.8% drawdown from 52-week high; 2 other insiders bought within 14 days.

William A. Houlihan, a director, purchased 3,000 shares at $1.59, adding to holdings that now total 240,732 shares. The stock is trading at -43.8% from its 52-week high of $2.83 and has declined -27.1% over the past 90 days, creating a substantially lower entry point than recent price history. His cross-ticker track record shows mixed timing: 2 prior open-market buys averaged +8.1% in 30-day returns but only +1.7% in 90-day returns with a 50% win rate. At this specific ticker (LFT), his prior two buys in 2023 showed one well-timed outcome at the 90-day mark but modest gains overall. Most notably, the filing reflects a cluster pattern: 2 other insiders also bought within the past 14 days, suggesting multiple insiders are accumulating at depressed prices—a potential signal that management views current valuations as attractive relative to fundamentals (P/E 8.37, market cap $83.3M).